BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 35166480)

  • 1. [Comparative pathomorphological characteristics of idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis].
    Samsonova MV; Chernyaev AL; Dvorakovskaya IV; Kusraeva EV
    Arkh Patol; 2022; 84(1):59-66. PubMed ID: 35166480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration and Application of Radiologic Patterns From Clinical Practice Guidelines on Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis.
    Marinescu DC; Hague CJ; Muller NL; Murphy D; Churg A; Wright JL; Al-Arnawoot A; Bilawich AM; Bourgouin P; Cox G; Durand C; Elliot T; Ellis J; Fisher JH; Fladeland D; Grant-Orser A; Goobie GC; Guenther Z; Haider E; Hambly N; Huynh J; Johannson KA; Karjala G; Khalil N; Kolb M; Leipsic J; Lok S; MacIsaac S; McInnis M; Manganas H; Marcoux V; Mayo J; Morisset J; Scallan C; Sedlic T; Shapera S; Sun K; Tan V; Wong AW; Zheng B; Ryerson CJ
    Chest; 2023 Dec; 164(6):1466-1475. PubMed ID: 37541339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of peripheral neutrophil to lymphocyte ratio and peripheral monocyte levels to predict survival in fibrotic hypersensitivity pneumonitis (fHP): a multicentre retrospective cohort study.
    Barratt SL; Creamer AW; Adamali HI; Duckworth A; Fallon J; Fidan S; Nancarrow T; Wollerton R; Steward M; Gooptu B; Gibbons M; Woodhead FA; Scotton C
    BMJ Open Respir Res; 2021 Nov; 8(1):. PubMed ID: 34794958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GDF15 as a potential biomarker to distinguish fibrotic from non-fibrotic hypersensitivity pneumonitis.
    Alarcon-Dionet A; Ruiz A; Chavez-Galan L; Buendia-Roldan I; Selman M
    Sci Rep; 2024 Jan; 14(1):859. PubMed ID: 38195721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes.
    Chen X; Yang X; Ren Y; Xie B; Xie S; Zhao L; Wang S; Geng J; Jiang D; Luo S; He J; Shu S; Hu Y; Zhu L; Li Z; Zhang X; Liu M; Dai H
    Chin Med J (Engl); 2023 Dec; 136(23):2839-2846. PubMed ID: 37464421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomic and network analysis identifies shared and unique pathways and immune changes across fibrotic interstitial lung diseases.
    Liu W; Huang K; Yang XZ; Wang P
    Aging (Albany NY); 2024 Feb; 16(4):3200-3230. PubMed ID: 38349858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association between Exposures and Disease Characteristics in Familial Pulmonary Fibrosis.
    Copeland CR; Donnelly EF; Mehrad M; Ding G; Markin CR; Douglas K; Wu P; Cogan JD; Young LR; Bartholmai BJ; Martinez FJ; Flaherty KR; Loyd JE; Lancaster LH; Kropski JA; Blackwell TS; Salisbury ML
    Ann Am Thorac Soc; 2022 Dec; 19(12):2003-2012. PubMed ID: 35877079
    [No Abstract]   [Full Text] [Related]  

  • 8. [Morphology of hypersensitivity pneumonitis].
    Samsonova MV; Chernyaev AL
    Arkh Patol; 2024; 86(3):67-73. PubMed ID: 38881008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms and haplotypes of TOLLIP and MUC5B are associated with susceptibility and survival in patients with fibrotic hypersensitivity pneumonitis.
    Mota PC; Soares ML; Ferreira AC; Santos RF; Rufo JC; Vasconcelos D; Carvalho A; Guimarães S; Vasques-Nóvoa F; Cardoso C; Melo N; Alexandre AT; Coelho D; Novais-Bastos H; Morais A
    Pulmonology; 2024 Feb; ():. PubMed ID: 38309995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral Blood Single-Cell Sequencing Uncovers Common and Specific Immune Aberrations in Fibrotic Lung Diseases.
    Zhao AY; Unterman A; Abu Hussein N; Sharma P; Flint J; Yan X; Adams TS; Justet A; Sumida TS; Zhao J; Schupp JC; Raredon MSB; Ahangari F; Zhang Y; Buendia-Roldan I; Adegunsoye A; Sperling AI; Prasse A; Ryu C; Herzog E; Selman M; Pardo A; Kaminski N
    bioRxiv; 2023 Sep; ():. PubMed ID: 37786685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and Lung Function Changes in Hypersensitivity Pneumonitis According to Radiological Phenotypes Compared With Idiopathic Pulmonary Fibrosis.
    Juliá-Serdá G; Navarro-Esteva J; Doreste-Salgado L; Véliz-Flores I; Pestana-Santana R; González-Martín JM; Rodríguez-de Castro F
    Cureus; 2024 Mar; 16(3):e57307. PubMed ID: 38690457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the 2020 hypersensitivity pneumonitis guideline on the pathologic diagnosis of interstitial pneumonia.
    Ozasa M; Bychkov A; Zaizen Y; Tabata K; Uegami W; Yamano Y; Kataoka K; Johkoh T; Mukae H; Kondoh Y; Fukuoka J
    Sci Rep; 2023 Jun; 13(1):9318. PubMed ID: 37291357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Antigen Exposure on Outcomes and Treatment Response in Fibrotic Hypersensitivity Pneumonitis.
    Mullin ML; Fernandez G; Marinescu DC; Zheng B; Wong AW; Assayag D; Fisher JH; Johannson KA; Khalil N; Kolb M; Manganas H; Marcoux V; Morisset J; Min B; Farrand E; Ryerson CJ
    Chest; 2024 Jun; 165(6):1435-1443. PubMed ID: 38128609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological findings in lung biopsies with usual interstitial pneumonia: Definition of a new classification score for histological fibrotic stages.
    Makovická M; Vrbenská A; Makovický P; Durcová B; Škarda J; Kamarád V; Miklošová M; Rimárová K; Michalčová P; Kráľová K; Muri J
    Gen Physiol Biophys; 2024 Jan; 43(1):49-55. PubMed ID: 38312034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Diagnosis and Treatment of Pulmonary Fibrosis.
    Kreuter M; Ladner UM; Costabel U; Jonigk D; Heussel CP
    Dtsch Arztebl Int; 2021 Mar; 118(Forthcoming):152-62. PubMed ID: 33531115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMP14
    Peng D; Li J; Li Y; Bai L; Xiong A; He X; Li X; Ran Q; Zhang L; Jiang M; Wang J; Leung EL; Yang P; Li G
    Pharmacol Res; 2024 Feb; 200():107070. PubMed ID: 38218353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Pulmonary Fibrosis with a Collagen-Mimetic Peptide.
    Borgula IM; Shuvaev S; Abston E; Rotile NJ; Weigand-Whittier J; Zhou IY; Caravan P; Raines RT
    ACS Sens; 2023 Nov; 8(11):4008-4013. PubMed ID: 37930825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single Cell Analysis Reveals Novel Immune Perturbations in Fibrotic Hypersensitivity Pneumonitis.
    Zhao AY; Unterman A; Abu Hussein NS; Sharma P; Nekola F; Flint J; Yan X; Adams TS; Justet A; Sumida TS; Zhao J; Schupp JC; Raredon MSB; Ahangari F; Deluliis G; Zhang Y; Buendia-Roldan I; Adegunsoye A; Sperling AI; Prasse A; Ryu C; Herzog E; Selman M; Pardo A; Kaminski N
    Am J Respir Crit Care Med; 2024 Jun; ():. PubMed ID: 38924775
    [No Abstract]   [Full Text] [Related]  

  • 19. The Role of Immune Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis.
    Xu Y; Lan P; Wang T
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of the prognostic transcriptomic signature in fibrotic hypersensitivity pneumonitis (PREDICT) study.
    Fernández Pérez ER; Leach SM; Vestal B;
    ERJ Open Res; 2024 Jan; 10(1):. PubMed ID: 38264150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.